It is a relatively recent phenomenon wherein true “patient voice” is recognized as an essential asset in the development of medicines, a result of sustained patient advocacy and regulatory efforts. Now, as the patient voice rises, a long-standing communications gap between patients and those who innovate on their behalf is finally beginning to close.